These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 5806406)
1. [Use of gas chromatography in pharmaceutical analysis. X. Further studies on antitubercular drugs]. Calò A; Cardini C; Quercia V Boll Chim Farm; 1969 Mar; 108(3):175-9. PubMed ID: 5806406 [No Abstract] [Full Text] [Related]
2. [Identification and determination of antitubercular compounds]. Iwainsky H; Grunert M; Reutgen H; Sehrt I Pharmazie; 1970 Sep; 25(9):505-13. PubMed ID: 4922351 [No Abstract] [Full Text] [Related]
3. [Comparative results of the therapeutic action of morphazinamide and pyrazinamide combined with ethionamide in experimental tuberculosis in guinea pigs]. Rözewska M G Ital Chemioter; 1967; 14(1):49-57. PubMed ID: 5622725 [No Abstract] [Full Text] [Related]
4. Ion-pair chromatography for simultaneous analysis of ethionamide and pyrazinamide from their porous microparticles. Bhanushali CJ; Zidan AS; Rahman Z; Habib MJ AAPS PharmSciTech; 2013 Dec; 14(4):1313-20. PubMed ID: 23990078 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic monitoring of antituberculosis drugs by direct in-line extraction on a high-performance liquid chromatography system. Seifart HI; Kruger PB; Parkin DP; van Jaarsveld PP; Donald PR J Chromatogr; 1993 Sep; 619(2):285-90. PubMed ID: 8263100 [TBL] [Abstract][Full Text] [Related]
6. Application of the cobaltabisdicarbollide anion to the development of ion selective PVC membrane electrodes for tuberculosis drug analysis. Stoica AI; Viñas C; Teixidor F Chem Commun (Camb); 2008 Dec; (48):6492-4. PubMed ID: 19057756 [TBL] [Abstract][Full Text] [Related]
7. Automated chemiluminometric screening of counterfeit drugs of the antituberculosis agent pyrazinamide. Prior JA; Santos JL; Lima JL J AOAC Int; 2009; 92(3):830-6. PubMed ID: 19610375 [TBL] [Abstract][Full Text] [Related]
8. The colorimetric analysis of anti-tuberculosis fixed-dose combination tablets and capsules. Ellard GA Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S343-6; discussion S351-2. PubMed ID: 10593715 [TBL] [Abstract][Full Text] [Related]
9. [COMPARATIVE STUDIES ON THE TUBERCULOSTATIC ACTIVITY OF N-MORPHOLINOMETHYLPYRAZINAMIDE AND PYRAZINE-2-CARBOXAMIDE (PYRAZINAMIDE) IN VITRO AND IN VIVO]. FREERKSEN E; BOENICKE R; ROSENFELD M Arzneimittelforschung; 1963 Aug; 13():722-4. PubMed ID: 14085928 [No Abstract] [Full Text] [Related]
11. Mass fragmentographic determination of pyrazinamide and its metabolites in serum and urine. Roboz J; Suzuki R; Yü TF J Chromatogr; 1978 Jan; 147():337-47. PubMed ID: 621253 [TBL] [Abstract][Full Text] [Related]
12. [Gas chromatographic methods used for the control of some types of drugs]. Quercia V Farmaco Prat; 1970 Feb; 25(2):122-9. PubMed ID: 4396770 [No Abstract] [Full Text] [Related]
13. [Morphazinamide--clinical tolerance and side effects]. Lachowicz D; Siekierzyńska A; Styszewska H Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260 [No Abstract] [Full Text] [Related]
14. Gas chromatographic separation of some antitubercular drugs. Calò A; Cardini C; Quercia V J Chromatogr; 1968 Oct; 37(2):194-6. PubMed ID: 5724054 [No Abstract] [Full Text] [Related]
15. [Colloquium on class II antitubercular agents]. Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):312-34. PubMed ID: 5824388 [No Abstract] [Full Text] [Related]
16. [Research on metabolic degradation of morphazinamide]. Gialdronigrassi G; Grassi C Minerva Med; 1965 Sep; 56(70):2762-6. PubMed ID: 5852635 [No Abstract] [Full Text] [Related]
18. [PRELIMINARY RESEARCH ON THE PHARMACODYNAMICS OF MORPHAZINAMIDE]. GRASSI C G Ital Chemioter; 1963; 10():212-3. PubMed ID: 14079406 [No Abstract] [Full Text] [Related]
19. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs]. Zunić D Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047 [No Abstract] [Full Text] [Related]